3

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: September 26, 2011
Period of Report: July 20, 2011
Accession Number: 0001513160-11-000059

View Document ↗ View on SEC.gov ↗